IL6 and brain neoplasm: These variables include systemic corticosteroid use and inflammatory markers such as interleukin-6 (IL-6), c-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), which all have associations between elevated levels and poor prognosis in brain tumor patients (57, 58).